Literature DB >> 2411542

Autoantibodies to ribonucleoprotein particles containing U2 small nuclear RNA.

W Habets, M Hoet, P Bringmann, R Lührmann, W van Venrooij.   

Abstract

Autoantibodies exclusively precipitating U1 and U2 small nuclear ribonucleoprotein (snRNP) particles [anti-(U1,U2)RNP] were detected in sera from four patients with autoimmune disorders. When tested by immunoblotting, these sera recognized up to four different protein antigens in purified mixtures of U1-U6 RNP particles. With purified antibody fractions eluted from individual antigen bands on nitrocellulose blots, each anti-(U1,U2)RNP serum precipitated U2 RNP by virtue of the recognition of a U2 RNP-specific B" antigen (mol. wt. 28 500). Antibodies to the U2 RNP-specific A' protein (mol. wt. 31 000) were found in only one serum. The B" antigen differs slightly in mol. wt. from the U1-U6 RNA-associated B/B' antigens and can be separated from this doublet by two-dimensional gel electrophoresis, due to its more acidic pI. In immunoprecipitation assays, the purified anti-B" antibody specificity also reacts with U1 RNPs which is due to cross-reactivity of the antibody with the U1 RNA-specific A protein, as demonstrated by immunoblotting using proteins from isolated U1 RNPs as antigenic material. Thus the A antigen not only bears unique antigenic sites for anti-A antibodies contained in anti-(U1)RNP sera, it also shares epitopes with the U2 RNP-specific B" antigen.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2411542      PMCID: PMC554380          DOI: 10.1002/j.1460-2075.1985.tb03815.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  33 in total

1.  Identification of antibodies to nuclear acidic antigens by counterimmunoelectrophoresis.

Authors:  N Kurata; E M Tan
Journal:  Arthritis Rheum       Date:  1976 May-Jun

2.  High resolution two-dimensional electrophoresis of basic as well as acidic proteins.

Authors:  P Z O'Farrell; H M Goodman; P H O'Farrell
Journal:  Cell       Date:  1977-12       Impact factor: 41.582

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 4.  Snurps and scyrps.

Authors:  M R Lerner; J A Steitz
Journal:  Cell       Date:  1981-08       Impact factor: 41.582

5.  Characterization of U small nuclear RNA-associated proteins.

Authors:  P B Billings; S O Hoch
Journal:  J Biol Chem       Date:  1984-10-25       Impact factor: 5.157

6.  Novel models for RNA splicing that involve a small nuclear RNA.

Authors:  Y Ohshima; M Itoh; N Okada; T Miyata
Journal:  Proc Natl Acad Sci U S A       Date:  1981-07       Impact factor: 11.205

7.  A small nuclear ribonucleoprotein is required for splicing of adenoviral early RNA sequences.

Authors:  V W Yang; M R Lerner; J A Steitz; S J Flint
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205

8.  An evaluation of small nuclear RNA in hnRNP.

Authors:  H Gallinaro; M Jacob
Journal:  FEBS Lett       Date:  1979-08-01       Impact factor: 4.124

9.  Antibodies to small nuclear RNAs complexed with proteins are produced by patients with systemic lupus erythematosus.

Authors:  M R Lerner; J A Steitz
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

10.  hnRNA and its attachment to a nuclear protein matrix.

Authors:  C A van Eekelen; W J van Venrooij
Journal:  J Cell Biol       Date:  1981-03       Impact factor: 10.539

View more
  43 in total

Review 1.  Mapping of epitopes recognized by anti-(U1)RNP autoantibodies.

Authors:  H H Guldner
Journal:  Mol Biol Rep       Date:  1992-06       Impact factor: 2.316

2.  U1-U2 snRNPs interaction induced by an RNA complementary to the 5' end sequence of U1 snRNA.

Authors:  M C Daugeron; J Tazi; P Jeanteur; C Brunel; G Cathala
Journal:  Nucleic Acids Res       Date:  1992-07-25       Impact factor: 16.971

3.  Purification of the major UsnRNPs from broad bean nuclear extracts and characterization of their protein constituents.

Authors:  Z Pálfi; M Bach; F Solymosy; R Lührmann
Journal:  Nucleic Acids Res       Date:  1989-02-25       Impact factor: 16.971

4.  Genetic studies of the PRP11 gene of Saccharomyces cerevisiae.

Authors:  K Schappert; J D Friesen
Journal:  Mol Gen Genet       Date:  1991-04

5.  Evidence for three distinct D proteins, which react differentially with anti-Sm autoantibodies, in the cores of the major snRNPs U1, U2, U4/U6 and U5.

Authors:  T Lehmeier; K Foulaki; R Lührmann
Journal:  Nucleic Acids Res       Date:  1990-11-25       Impact factor: 16.971

6.  Recognition of U1 and U2 small nuclear RNAs can be altered by a 5-amino-acid segment in the U2 small nuclear ribonucleoprotein particle (snRNP) B" protein and through interactions with U2 snRNP-A' protein.

Authors:  R C Bentley; J D Keene
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

7.  Comparison of assay systems for detecting antibodies to nuclear ribonucleoproteins.

Authors:  P Merryman; P Louie
Journal:  J Clin Pathol       Date:  1991-08       Impact factor: 3.411

8.  Distinctive immune response patterns of human and murine autoimmune sera to U1 small nuclear ribonucleoprotein C protein.

Authors:  M Satoh; J J Langdon; K J Hamilton; H B Richards; D Panka; R A Eisenberg; W H Reeves
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

9.  Nuclear organization and dynamics of 7SK RNA in regulating gene expression.

Authors:  Kannanganattu V Prasanth; Matthew Camiolo; Grace Chan; Vidisha Tripathi; Laurence Denis; Tetsuya Nakamura; Michael R Hübner; David L Spector
Journal:  Mol Biol Cell       Date:  2010-09-29       Impact factor: 4.138

10.  Independent deposition of heterogeneous nuclear ribonucleoproteins and small nuclear ribonucleoprotein particles at sites of transcription.

Authors:  S A Amero; G Raychaudhuri; C L Cass; W J van Venrooij; W J Habets; A R Krainer; A L Beyer
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.